Development and evaluation of anthrax vaccine powder formulations for nasal mucosal delivery.

被引：0
|
作者：
Jiang, G
Sullivan, V
Mikszta, J
Joshi, S
Middaugh, CR
Huang, J
Alarcon, J
Ferriter, M
Woodley, W
Ford, B
Mar, K
Roy, C
Ulrich, R
Harvey, N
机构：
[1] BD Technol, Dept Adv Drug Delivery, Res Triangle Pk, NC 27709 USA
[2] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 228卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
182-BIOL
引用
收藏
页码：U201 / U201
页数：1
相关论文
共 50 条
  • [1] Anthrax vaccine powder formulations for nasal mucosal delivery
    Jiang, G
    Joshi, SB
    Peek, LJ
    Brandau, DT
    Huang, J
    Ferriter, MS
    Woodley, WD
    Ford, BM
    Mar, KD
    Mikszta, JA
    Hwang, CR
    Ulrich, R
    Harvey, NG
    Middaugh, CR
    Sullivan, VJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (01) : 80 - 96
  • [2] Stable dry powder formulation for nasal delivery of anthrax vaccine
    Wang, Sheena H.
    Kirwan, Shaun M.
    Abraham, Soman N.
    Staats, Herman F.
    Hickey, Anthony J.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (01) : 31 - 47
  • [3] Development of a cold-adapted influenza vaccine for nasal delivery.
    Backer, MP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U324 - U324
  • [4] First in vivo evaluation of particulate nasal dry powder vaccine formulations containing ovalbumin in mice
    Scherliess, Regina
    Moenckedieck, Mathias
    Young, Katherine
    Trows, Sabrina
    Buske, Simon
    Hook, Sarah
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 479 (02) : 408 - 415
  • [5] Formulation of a dry powder influenza vaccine for nasal delivery
    Robert J. Garmise
    Kevin Mar
    Timothy M. Crowder
    C. Robin Hwang
    Matthew Ferriter
    Juan Huang
    John A. Mikszta
    Vincent J. Sullivan
    Anthony J. Hickey
    AAPS PharmSciTech, 7
  • [6] Formulation of a dry powder influenza vaccine for nasal delivery
    Garmise, RJ
    Mar, K
    Crowder, TM
    Hwang, CR
    Ferriter, M
    Huang, J
    Mikszta, JA
    Sullivan, VJ
    Hickey, AJ
    AAPS PHARMSCITECH, 2006, 7 (01) : E1 - E7
  • [7] Development and evaluation of nasal formulations of ketorolac
    Quadir, M
    Zia, H
    Needham, TE
    DRUG DELIVERY, 2000, 7 (04) : 223 - 229
  • [8] Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
    Anggraeni, Rahmi
    Ana, Ika Dewi
    Wihadmadyatami, Nevi
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2022, 11 (03) : 235 - 248
  • [9] Development and testing of particulate formulations for the nasal delivery of antibodies
    Kaye, Richard S.
    Purewal, Tarlochan S.
    Alpar, Oya H.
    JOURNAL OF CONTROLLED RELEASE, 2009, 135 (02) : 127 - 135
  • [10] Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity
    Liu, Jun
    Yan, Xiao-Dan
    Li, Xian-Qiang
    Du, Yu-Hao
    Zhu, Li-Li
    Ye, Tian-Tian
    Cao, Ze-Ying
    Dong, Zhe-Wen
    Li, Shu-Tao
    Xu, Xue
    Bai, Wei
    Li, Dan
    Zhang, Ji-Wen
    Wang, Shu-Jun
    Li, Shan-Hu
    Sun, Jin
    Yin, Xian-Zhen
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345